Industry reports
Editor highlights

2013 The Multiple Beverage Marketplace in the US

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Birch Pollen Allergy – Pipeline Review, H1 2013

Birch Pollen Allergy – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 40 pages

Birch Pollen Allergy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete ...

Haemophilus Influenzae Type b Infections – Pipeline Review, H1 2013

Haemophilus Influenzae Type b Infections – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 48 pages

Haemophilus Influenzae Type b Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development ...

Hemorrhage – Pipeline Review, H1 2013

Hemorrhage – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 38 pages

Hemorrhage – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hemorrhage - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hemorrhage, complete with latest updates, and special ...

Viral Conjunctivitis – Pipeline Review, H1 2013

Viral Conjunctivitis – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 49 pages

Viral Conjunctivitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Viral Conjunctivitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Viral Conjunctivitis, complete ...

Diabetic Complications – Pipeline Review, H1 2013

Diabetic Complications – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 40 pages

Diabetic Complications – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetic Complications - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Complications, complete ...

Hereditary Angioedema (HAE) – Pipeline Review, H1 2013

Hereditary Angioedema (HAE) – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 69 pages

Hereditary Angioedema (HAE) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hereditary Angioedema (HAE) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hereditary Angioedema ...

Mixed Dyslipidemia – Pipeline Review, H1 2013

Mixed Dyslipidemia – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 46 pages

Mixed Dyslipidemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Mixed Dyslipidemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Mixed Dyslipidemia, complete with ...

Neurofibromatoses – Pipeline Review, H1 2013

Neurofibromatoses – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 41 pages

Neurofibromatoses – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neurofibromatoses - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neurofibromatoses, complete with latest ...

Warts – Pipeline Review, H1 2013

Warts – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 60 pages

Warts – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Warts - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Warts, complete with latest updates, and special features on ...

Sjogren%s Syndrome – Pipeline Review, H1 2013

Sjogren%s Syndrome – Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • May 2013
  • 35 pages

Sjogren's Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sjogren's Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Sjogren's Syndrome, complete with ...

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.